65
IRUS Total
Downloads

Contribution of glucose to increased respiratory bacterial burden in hyperglycaemia

File Description SizeFormat 
Gill-S-2017-PhD-Thesis.pdfThesis3.89 MBAdobe PDFView/Open
Title: Contribution of glucose to increased respiratory bacterial burden in hyperglycaemia
Authors: Gill, Simren Kaur
Item Type: Thesis or dissertation
Abstract: It has recently been proposed that uncontrolled hyperglycaemia in people with diabetes increases lung glucose, so providing a richer growth medium facilitating bacterial infection. Where diabetes is controlled, there is a reduced associated risk of bacterial infection. The aim of this thesis was to determine the effect of glucose on bacterial growth in vivo and directly link bacterial glucose metabolism with increased respiratory tract bacterial load in hyperglycaemia. P. aeruginosa, a Gram-negative opportunistic pathogen, which is a major cause of respiratory infections, was used as chronic P. aeruginosa infections are most commonly associated with people with cystic fibrosis (CF) and chronic obstructive pulmonary diseases (COPD), but importantly P. aeruginosa is increasingly diagnosed in diabetic patients with pneumonia/lung infection. To test the hypothesis, P. aeruginosa mutants were generated by deleting oprB, gltK, gtrS and glk genes and these mutant strains were used in in vitro and in vivo infection models developed during this thesis. The mutants had drastically reduced growth in minimal medium containing glucose as the sole carbon source, whereas they were unaltered when grown in rich medium. In order to explore the effect of elevated glucose with minimal effects on the immune response, streptozocin was used to induce diabetes, instead of genetically obese mice, which have a complex phenotype and impaired immune responses. Streptozocin induced hyperglycaemia also led to increased bacterial load in the airways when mice were infected with wild type PAO1 but not with the glucose uptake and metabolism mutants. To further support this hypothesis when metformin was used to lower glucose levels it resulted in a reduced bacterial burden.
Content Version: Open Access
Issue Date: Dec-2016
Date Awarded: Mar-2017
URI: http://hdl.handle.net/10044/1/67941
DOI: https://doi.org/10.25560/67941
Supervisor: Tregoning, John
Filloux, Alain
Sponsor/Funder: Wellcome Trust (London, England)
Department: Department of Medicine
Publisher: Imperial College London
Qualification Level: Doctoral
Qualification Name: Doctor of Philosophy (PhD)
Appears in Collections:Medicine PhD theses



Unless otherwise indicated, items in Spiral are protected by copyright and are licensed under a Creative Commons Attribution NonCommercial NoDerivatives License.

Creative Commons